News about neuroprotectants for the treatment of stroke.
Mitka
Mike
M
D002986:Clinical Trials as Topic; D003566:Cytidine Diphosphate Choline / Q000627:therapeutic use; D018691:Excitatory Amino Acid Antagonists; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D008278:Magnesium Sulfate / Q000627:therapeutic use; D018696:Neuroprotective Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D010713:Phosphatidylcholines / Q000627:therapeutic use; D020521:Stroke / Q000188:drug therapy*; D013997:Time Factors
D018691:Excitatory Amino Acid Antagonists; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D018696:Neuroprotective Agents; D010713:Phosphatidylcholines; D003566:Cytidine Diphosphate Choline; D008278:Magnesium Sulfate